Line 19: | Line 19: | ||
<p>The sequence of the <em>qnrS1</em> gene was amplified from the gBlock <em>qnrS1</em> | <p>The sequence of the <em>qnrS1</em> gene was amplified from the gBlock <em>qnrS1</em> | ||
E. coli ordered from IDT. Primers used for the | E. coli ordered from IDT. Primers used for the | ||
− | amplification were F-qnrs1 <em>E.coli</em> and R-qnrs1 <em>E.coli/<em> (primer sequences can be found <a href="https://2016.igem.org/Team:Groningen/Experiments#primer-list">here</a>). | + | amplification were F-qnrs1 <em>E.coli</em> and R-qnrs1 <em>E.coli/</em> (primer sequences can be found <a href="https://2016.igem.org/Team:Groningen/Experiments#primer-list">here</a>). |
<h5>PCR mixture:</h5> | <h5>PCR mixture:</h5> |
Latest revision as of 22:05, 19 October 2016
To design a ciprofloxacin resistance cassette we designed a gBlock that contains the Bacillus subtilis promoter PAtpI, which is active from a very early stage of germination and includes a ribosome binding site. The gBlock also contains the original qnrS1 gene sequence from E. coli. qnr genes code for pentapeptide repeat proteins. These proteins reduce susceptibility to quinolones by protecting the complex of DNA and DNA gyrase enzyme from the inhibitory effect of quinolones. Finally, this gBlock contains a double terminator BBa_B0015 from iGEM as well as the prefix and suffix for BioBricks. In summary the ciprofloxacin cassette consists of the following parts PAtpI+RBS+qnrS1+2TER.BBa_K823023 is an available BioBrick from igem Munich 2012. It is an
integration plasmid for Bacillus subtilis, which can be used for
cloning in E. coli as well. An RFP is inserted in BBa_K823023 for more
efficient screening after transformation. Construction of ciprofloxacin resistance cassette in BBa_K823023 integration plasmid was performed as described in the following. The sequence of the qnrS1 gene was amplified from the gBlock qnrS1
E. coli ordered from IDT. Primers used for the
amplification were F-qnrs1 E.coli and R-qnrs1 E.coli/ (primer sequences can be found here).
50 µl PCR assay was performed according to the following
protocol. For detailed information on how to prepare and run agarose gels see
following protocol. The PCR of the qnrS1 sequence from the IDT gBlock was successful. It
was verified by DNA electrophoresis. A band with the correct
size of 1,194 bp could be seen. PCR product was subsequently cleaned with (PCR Purification Kit – Jena Bioscience). 28/09/16: The qnrS1 PCR product and BBa_K823023 were cut with the
restriction enzymes EcoRI and PstI. 20 μl RD assay was performed according to the following protocol. For detailed information on how to prepare and run
agarose gels see following protocol. The digestion of BBa_K823023 showed the correct bands on the gel. 6,000 bp backbone for the backbone and the 1000 bp for the RFP insert. Therefore the cloning procedure could proceed. Digested sample of the backbone ~6,000 bp were cut out from the
gel and DNA was extracted by Agarose gel extraction kit (Jena Bioscience)
(see protocol). The digestion of the qnrS1 PCR product was immediately cleaned with
the kit (PCR Purification Kit – Jena Bioscience). 19/10 In this ligation the EcoRI, PstI cut gene qnrS1 and the vector
BBa_K823023 were combined. 20 µl ligation assay was performed according to the following protocol. 29/09/16: The ligation mix was heat shock transformed to competent Top10 E. coli cells following the protocol. Cells
were plated on 100 μg/ml ampicillin LB agar to select for the correct
constructs. On the next day colonies were selected to perform colony PCR in
order to find the correct constructs using the primers F-qnrs1 E.coli
and R-qnrs1 E.coli. Primer sequences can be found here.
25 µl PCR assay was performed according to the following
protocol. For detailed information on how to prepare and run agarose gel see following protocol. The transformation of qrnS1 (ciprofloxacin resistance cassette) in BBa_K823023 to E. coli Top10 was successful. To test if the construct would make B. subtilis resistant to
ciprofloxacin, the construct qrnS1 in BBa_K823023 was transformed into the B.
subtilis 168 tpr+. 13/10/16: The transformation to B. subtilis was performed according to the following protocol. Colonies were selected on LB agar
with 5 μg/ml chloramphenicol. 14/10/16: Colonies were streaked out on agar with starch to perform the
starch test, which verifies the integration in the amyE locus in the
genome of B. subtilis. Integration check: Starch test The integration of the ciprofloxacin resistance cassette was
successful. As a first check on the functionality of the ciprofloxacin
resistance cassette, we grew B. subtilis colonies from the starch test
with ciprofloxacin. As a control they were also grown with
chloramphenicol, the resistance on the backbone of the integration
vector. Figure 7 shows the result for 3 different colonies (tubes
indicated with 1 - 3). The tubes marked with Cm is the control with
chloramphenicol, which shows growth for all three colonies. The tubes
marked with Cipro were grown with ciprofloxacin. Colonies 2 and 3 showed
growth, whereas colony 1 did not grow. Seems like the resistance
cassette is working. To further explore if the ciprofloxacin cassette
is functional in B. subtilis, a MIC value test was performed. See link.Ciprofloxacin resistance cassette in BBa_K823023
PCR
Experiment:
PCR mixture:
PCR set-up:
95ºC 2:00 min 95ºC 30s (12X) 60ºC 30s (12X) 72ºC 1:30 min (12X) 72ºC 2:00 min 10ºC on hold DNA Electrophoresis:
Conclusion:
Procedure after gel validation:
Restriction digestion
Experiment:
RD mixture:
DNA Electrophoresis:
Conclusion:
Procedure after gel validation:
Ligation
Ligation mixture:
Transformation
Experiment:
PCR mixture:
PCR set-up:
95ºC 2:00 min 95ºC 30s (30X) 60ºC 30s (30X) 72ºC 1:30 min (30X) 72ºC 2:00 min 10ºC on hold DNA electrophoresis:
Conclusion:
Validation
Experiment:
Experiments
Experiment:
Conclusion: